An encapsulation of iron homeostasis and virulence in Cryptococcus neoformans

Trends in Microbiology

Volumn 21, Issue 9, 2013, Pages 457-465

  Kronstad, James W ^a   Hu, Guanggan ^a   Jung, Won Hee ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Chung Ang University   (South Korea)

Author keywords

Capsule; Cell wall; Fungal pathogenesis; Heme; Melanin; PH; Signaling; Virulence

Indexed keywords

CIG1 PROTEIN; ESCRT PROTEIN; HEME; IRON; MANNOPROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL VIRULENCE; CELL ENCAPSULATION; CFO1 GENE; CFT1 GENE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HUMAN; IRON METABOLISM; IRON TRANSPORT; MOLECULAR PATHOLOGY; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

FILOBASIDIELLA NEOFORMANS; FUNGI; VERTEBRATA;

CAPSULE; CELL WALL; FUNGAL PATHOGENESIS; HEME; MELANIN; PH; SIGNALING; VIRULENCE;

ANIMALS; BIOLOGICAL TRANSPORT; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FUNGAL PROTEINS; HOMEOSTASIS; HUMANS; IRON;

EID: 84883758675     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2013.05.007     Document Type: Review

References (74)

1. Park B.J., et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23:525-530.
2. Bartlett K.H., et al. The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest. Curr. Fungal Infect. Rep. 2007, 1:108-115.
3. Byrnes E.J., et al. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog. 2010, 6:e1000850.
4. Harris J.R., et al. Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. Clin. Infect. Dis. 2011, 53:1188-1195.
5. Brown G.D., et al. Hidden killers: human fungal infections. Sci. Transl. Med. 2012, 4:165rv13.
6. Jung W.H., et al. Iron regulation of the major virulence factors in the AIDS-associated pathogen Cryptococcus neoformans. PLoS Biol. 2006, 4:e410.
7. Skaar E.P. The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog. 2010, 6:e1000949.
8. Sutak R., et al. Crusade for iron: iron uptake in unicellular eukaryotes and its significance for virulence. Trends Microbiol. 2008, 16:261-268.
9. Almeida R.S., et al. Candida albicans iron acquisition within the host. FEMS Yeast Res. 2009, 9:1000-1012.
10. Kornitzer D. Fungal mechanisms for host iron acquisition. Curr. Opin. Microbiol. 2009, 12:377-383.
11. Haas H. Iron - a key nexus in the virulence of Aspergillus fumigatus. Front. Microbiol. 2012, 3:28.
12. Barluzzi R., et al. Iron overload exacerbates experimental meningoencephalitis by Cryptococcus neoformans. J. Neuroimmunol. 2002, 132:140-146.
13. Singh N., Sun H.Y. Iron overload and unique susceptibility of liver transplant recipients to disseminated disease due to opportunistic pathogens. Liver Transpl. 2008, 14:1249-1255.
14. Sifri C.D., et al. Pretransplant cryptococcosis and outcome after liver transplantation. Liver Transpl. 2010, 16:499-502.
15. Jung W.H., Kronstad J.W. Iron and fungal pathogenesis: a case study with Cryptococcus neoformans. Cell. Microbiol. 2008, 10:277-284.
16. Kumar P., et al. Emerging themes in cryptococcal capsule synthesis. Curr. Opin. Struct. Biol. 2011, 21:597-602.
17. Liu G.Y., Nizet V. Color me bad: microbial pigments as virulence factors. Trends Microbiol. 2009, 17:406-413.
18. Reese A.J., Doering T.L. Cell wall α-1,3-glucan is required to anchor the Cryptococcus neoformans capsule. Mol. Microbiol. 2003, 50:1401-1409.
19. Kronstad J.W., et al. Expanding fungal pathogenesis: Cryptococcus species break out of the opportunistic box. Nat. Rev. Microbiol. 2011, 9:193-203.
20. Vartivarian S.E., et al. Regulation of cryptococcal capsular polysaccharide by iron. J. Infect. Dis. 1993, 167:186-190.
21. O'Meara T.R., Alspaugh J.A. The Cryptococcus neoformans capsule: a sword and a shield. Clin. Microbiol. Rev. 2012, 25:387-408.
22. Silva M.G., et al. The homeostasis of iron, copper, and zinc in Paracoccidioides brasiliensis, Cryptococcus neoformans var. grubii, and Cryptococcus gattii: a comparative analysis. Front. Microbiol. 2011, 2:49.
23. Jung W.H., et al. Iron source preference and regulation of iron uptake in the AIDS-associated pathogen Cryptococcus neoformans. PLoS Pathog. 2008, 4:e45.
24. Jung W.H., et al. The role of ferroxidases in iron uptake and virulence of Cryptococcus neoformans. Eukaryot. Cell 2009, 8:1511-1520.
25. Tangen K.T., et al. The iron and cAMP regulated gene SIT1 influences siderophore utilization, melanization and cell wall structure in Cryptococcus neoformans. Microbiology 2007, 153:29-41.
26. Cadieux B., et al. The mannoprotein Cig1 supports iron acquisition from heme and virulence in the pathogenic fungus Cryptococcus neoformans. J. Infect. Dis. 2013, 207:1339-1347.
27. Kosman D.J. Iron metabolism in aerobes: managing ferric iron hydrolysis and ferrous iron autoxidation. Coord. Chem. Rev. 2013, 257:210-217.
28. Hu G., et al. Metabolic adaptation in Cryptococcus neoformans during early murine pulmonary infection. Mol. Microbiol. 2008, 69:1456-1475.
29. Fan W., et al. Cryptococcus neoformans gene expression during murine macrophage infection. Eukaryot. Cell 2005, 4:1420-1433.
30. Han K., et al. A human fungal pathogen Cryptococcus neoformans expresses three distinct iron permease homologs. J. Microbiol. Biotechnol. 2012, 22:1644-1652.
31. Kim J., et al. A defect in iron uptake enhances the susceptibility of Cryptococcus neoformans to azole antifungal drugs. Fungal Genet. Biol. 2012, 49:955-966.
32. Jung W.H., et al. HapX positively and negatively regulates the transcriptional response to iron deprivation in Cryptococcus neoformans. PLoS Pathog. 2010, 6:e1001209.
33. Lian T.S., et al. Iron-regulated transcription and capsule formation in the fungal pathogen Cryptococcus neoformans. Mol. Microbiol. 2005, 55:1452-1472.
34. Crestani J., et al. Proteomic profiling of the influence of iron availability on Cryptococcus gattii. J. Proteome Res. 2012, 11:189-205.
35. Hu G., et al. Cryptococcus neoformans requires the ESCRT protein Vps23 for iron acquisition from heme, capsule formation and virulence. Infect. Immun. 2013, 81:292-302.
36. Biondo C., et al. Identification of major proteins secreted by Cryptococcus neoformans. FEMS Yeast Res. 2006, 6:645-651.
37. O'Meara T.R., et al. Interaction of Cryptococcus neoformans Rim101 and protein kinase A regulates capsule. PLoS Pathog. 2010, 6:e1000776.
38. Stojiljkovic I., et al. Antimicrobial properties of porphyrins. Expert Opin. Investig. Drugs 2001, 10:309-320.
39. Foley T.L., Simeonov A. Targeting iron assimilation to develop new antibacterials. Expert Opin. Drug Discov. 2012, 7:831-847.
40. Weissman Z., et al. An endocytic mechanism for haemoglobin-iron acquisition in Candida albicans. Mol. Microbiol. 2008, 69:201-217.
41. Davis D.A. How human pathogenic fungi sense and adapt to pH: the link to virulence. Curr. Opin. Microbiol. 2009, 12:365-370.
42. Kronstad J.W., et al. Adaptation of Cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence. Eukaryot. Cell 2012, 11:109-118.
43. Choi J.N., et al. Influence of iron regulation on the metabolome of Cryptococcus neoformans. PLoS ONE 2012, 7:e41654.
44. Cramer K.L., et al. Transcription factor Nrg1 mediates capsule formation, stress response, and pathogenesis in Cryptococcus neoformans. Eukaryot. Cell 2006, 5:1147-1156.
45. O'Meara T.R., et al. Cryptococcus neoformans Rim101 is associated with cell wall remodeling and evasion of the host immune responses. mBio 2013, 4:e00522.
46. Dias-Melicio L.A., et al. Chloroquine inhibits Paracoccidioides brasiliensis survival within human monocytes by limiting the availability of intracellular iron. Microbiol. Immunol. 2006, 50:307-314.
47. Dias-Melicio L.A., et al. Chloroquine is therapeutic in murine experimental model of paracoccidioidomycosis. FEMS Immunol. Med. Microbiol. 2007, 50:133-143.
48. Mazzolla R., et al. Enhanced resistance to Cryptococcus neoformans infection induced by chloroquine in a murine model of meningoencephalitis. Antimicrob. Agents Chemother. 1997, 41:802-807.
49. Newman S.L., et al. Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J. Clin. Invest. 1994, 93:1422-1429.
50. Harrison T.S., et al. Conditional lethality of the diprotic weak bases chloroquine and quinacrine against Cryptococcus neoformans. J. Infect. Dis. 2000, 182:283-289.
51. Weber S.M., et al. Chloroquine and the fungal phagosome. Curr. Opin. Microbiol. 2000, 3:349-353.
52. Alteri C.J., et al. Mucosal immunization with iron receptor antigens protects against urinary tract infection. PLoS Pathog. 2009, 5:e1000586.
53. Ibrahim A.S., et al. The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis. Mol. Microbiol. 2010, 77:587-604.
54. Brena S., et al. Fungicidal monoclonal antibody C7 interferes with iron acquisition in Candida albicans. Antimicrob. Agents Chemother. 2011, 55:3156-3163.
55. Liu Y., Filler S.G. Candida albicans Als3, a multifunctional adhesin and invasin. Eukaryot. Cell 2011, 10:168-173.
56. Möllmann U., et al. Siderophores as drug delivery agents: application of the "Trojan Horse" strategy. Biometals 2009, 22:615-624.
57. Bernier G., et al. Desketoneoenactin-siderophore conjugates for Candida: evidence of iron transport-dependent species selectivity. Antimicrob. Agents Chemother. 2005, 49:241-248.
58. Zarember K.A., et al. Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob. Agents Chemother. 2009, 53:2654-2656.
59. Ibrahim A.S., et al. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J. Clin. Invest. 2007, 117:2649-2657.
60. Ibrahim A.S., et al. The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis. J. Antimicrob. Chemother. 2010, 65:289-292.
61. Ibrahim A.S., et al. Pathogenesis of mucormycosis. Clin. Infect. Dis. 2012, 54(Suppl. 1):S16-S22.
62. Spellberg B., et al. The Deferasirox-AmBisome therapy for mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J. Antimicrob. Chemother. 2012, 67:715-722.
63. Choi J., et al. Regulated expression of cyclic AMP-dependent protein kinase A reveals an influence on cell size and the secretion of virulence factors in Cryptococcus neoformans. Mol. Microbiol. 2012, 85:700-715.
64. Selvig K., Alspaugh J.A. pH response pathways in fungi: adapting to host-derived and environmental signals. Mycobiology 2011, 39:249-256.
65. Chun C.D., Madhani H.D. Ctr2 links copper homeostasis to polysaccharide capsule formation and phagocytosis inhibition in the human fungal pathogen Cryptococcus neoformans. PLoS ONE 2010, 5:e12503.
66. Robertson L.S., et al. The yeast A kinases differentially regulate iron uptake and respiratory function. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:5984-5988.
67. Eichhorn H., et al. A ferroxidation/permeation iron uptake system is required for virulence in Ustilago maydis. Plant Cell 2006, 18:3332-3345.
68. Hu G., et al. Transcriptional regulation by protein kinase A in Cryptococcus neoformans. PLoS Pathog. 2007, 3:e42.
69. Ko Y.J., et al. Remodeling of global transcription patterns of Cryptococcus neoformans genes mediated by the stress-activated HOG signaling pathways. Eukaryot. Cell 2009, 8:1197-1217.
70. Nyhus K.J., et al. Ferric iron reduction by Cryptococcus neoformans. Infect. Immun. 1997, 65:434-438.
71. Jacobson E.S., et al. Ferrous iron uptake in Cryptococcus neoformans. Infect. Immun. 1998, 66:4169-4175.
72. Jacobson E.S., Petro M.J. Extracellular iron chelation in Cryptococcus neoformans. J. Med. Vet. Mycol. 1987, 25:415-418.
73. Liu X., et al. Role of a VPS41 homologue in starvation response, intracellular survival and virulence of Cryptococcus neoformans. Mol. Microbiol. 2006, 61:1132-1146.
74. Solinger J.A., Spang A. Tethering complexes in the endocytic pathway: CORVET and HOPS. FEBS J. 2013, 280:2743-2757.